PPHF 2012 Public Health Laboratory Infrastructure financed solely by 2012 Prevention and Public Heal

Over the course of the cooperative agreement period, the Association of Public Health Laboratories (APHL) will engage in activities to strengthen public health infectious disease laboratory infrastructure by addressing gaps in public health laboratory practice, and assist with development, implementation
and ongoing support of laboratory technologies for use in public health.

The specific objectives may include but are not limited to:


Assess public health infectious disease laboratory capabilities and capacities by conducting and analyzing formal and informal surveys and other methodologies.

Convene Committees/Task Forces/Workgroups to develop or review guidelines and recommendations on PHL laboratory capacity and quality laboratory practice.

Provide training and other resources to address knowledge and capacity gaps.

Convene forums to exchange knowledge and build communities of practice and promote the role of public health laboratories in infectious disease control, especially in emerging infectious diseases.

Sustain and enhance strategic partnerships with governmental and non-governmental agencies and professional organizations including CDC, Centers for Medicare & Medicaid Services (CMS), Federal Drug Administration (FDA), American Society of Microbiology (ASM), Infectious Disease Society of America (IDSA), American Society for Clinical Pathology (ASCP), ASTHO, CSTE, NACCHO, National Tuberculosis Controllers Association (NTCA), Advisory Council for the Elimination of Tuberculosis (ACET), National Alliance of State and Territorial AIDS Directors (NASTAD), National Coalition of STD Directors (NCSD), and U.S.

Department of Defense to contribute to public policy development and reinforce and expand the role of public health laboratories in infectious disease detection and control.

Enhance communication and professional linkages regarding infectious diseases between public health laboratories and clinical and academic laboratories.

Provide expert consultation regarding infectious diseases to regulatory agencies and standard setting organizations (e.g., United States Department of Agriculture [USDA], FDA, and CMS).

Assure and enhance technology transfer from CDC and other agencies to public health laboratories.

Assuring knowledge of appropriate quality control by end users when technology is further transferred to community based organizations involved in infectious disease testing.

Provide programmatic and technical support to other focus areas, including policy, emergency preparedness, global health, informatics, and professional development.

Agency - Department of Health and Human Services

The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.

Website Address


Program Accomplishments

Not Applicable.

Uses and Use Restrictions

Project funds may be used for costs associated with planning, organizing, conducting, and supporting public health laboratory infrastructure programs, and for the implementation of other program elements as described in Section 050 above.

CDC s rules on allowable expenses must be followed.

Eligibility Requirements

Applicant Eligibility

Eligibility is limited to the Association of Public Health Laboratories (APHL), a private nonprofit organization and the current grantee.

CDC approved single eligibility of this award.

This group is the appropriate and only qualified organization to address the activities described under the program announcement.

Beneficiary Eligibility

Students/trainees and any U.S. state, political subdivision and U.S. territories (as described above), and other public entities will benefit.


Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, and provide a budget with justification of funds. Costs will be determined in accordance with 2 CFR 215 (OMB Circular No. A-122). OMB Circular No. A-110 applies to this program. This program is excluded from coverage under OMB Circular No. A-87.

Aplication and Award Process

Preapplication Coordination

Preapplication coordination is required.

Environmental impact information is not required for this program.

This program is excluded from coverage under E.O.


Application Procedures

This program is excluded from coverage under OMB Circular No. A-102. This program is excluded from coverage under OMB Circular No. A-110. To apply for this funding opportunity use application Form PHS 5161. Application forms and instructions are available on www.grants.gove and/or the CDC web site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm. If you do not have access to the Internet, or if you have difficulty accessing the forms on-line, you may contact the CDC Procurement and Grants Office Technical Information Management Section (PGO-TIMS) staff at 770-488-2700. Applicantion forms can be mailed to you.

Award Procedures

Successful applicants receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be the only binding, authorizing document between the recipient and CDC. The NoA will be signed by an authorized Grants Management Officer, and mailed to the recipient fiscal officer identified in the application. Unsuccessful applicants receive notification of the results of the application review by mail.


Contact the headquarters or regional office, as appropriate, for application deadlines.


Public Health Service Act, Section 317, 42 U.S.C 247b; Patient Protection and Affordable Care Act , Title IV, Section 4002.

Range of Approval/Disapproval Time

From 60 to 90 days.


Not Applicable.


Renewals will be based upon the conditions in the funding announcement and are subject to the availability of funds under Section 317 of the Public Health Service Act or under the Patient Protection and Affordable Care Act.

Assistance Considerations

Formula and Matching Requirements

This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.

Length and Time Phasing of Assistance

Financial assistance is provided for a 12-month budget period with project periods of up to five years subject to the availability of funds and satisfactory progress of the grantee. Method of awarding/releasing assistance: lump sum.

Post Assistance Requirements


Each funded applicant must provide CDC with an interim progress reports via www.grants.gov: 1.

The first interim progress report is due at mid year and will serve as the non-competing continuation application, and must contain the following elements: a.

Standard Form ("SF") 424S Form.


SF-424A Budget Information-Non-Construction Programs.


Budget Narrative.


Indirect Cost Rate Agreement.


Project Narrative.


The second report is due no later than 90 days after the end of the budget period.

This report should include a detailed description of specific projects and activities conducted, measurable outcomes achieved and public health impact resulting from projects conducted during the reporting period.


Annual progress report, due 90 days after the end of the budget period.

These reports must be submitted to the attention of the Grants Management Specialist.

No cash reports are required.

The reporting schedule will be based on the requirements listed in the funding opportunity announcement.

Interim progress report are required no less than 90 days before the end of the budget period.

The progress report will serve as your non-competing continuation application, and must contain the following elements: current budget period activities objectives, current budget period financial progress, new budget period program proposed activity objectives, budget, additional requested information, and measures of effectiveness.

Financial status report and annual progress report, no more than 90 days after the end of the budget period; and Final financial and performance reports, no more than 90 days after the end of the project period.

Performance monitoring is not applicable.


In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133.


Financial and personnel records including financial awards, financial status reports, interim reports, and final reports must be maintained for a period of seven years.

Financial Information

Account Identification



(Cooperative Agreements) FY 12 $28,000,000; FY 13 est $45,000,000; and FY 14 est $45,000,000 - Future year funding is subject to the availability of funds.

Range and Average of Financial Assistance

Awards will range from approximately $1 million to $3 million with an average of approximately $2 million.

Regulations, Guidelines, and Literature

Regulations governing this program are published under 42 CFR 55b. Guidelines are available for 45 CFR 92 and HHS Grants Policy statement at http://www.ahrq.gov/fund/hhspolicy.htm

Information Contacts

Regional or Local Office


Headquarters Office

MS E56
CDC, OSELS, ATLANTA, Georgia 30333 Email: SMH0@CDC.GOV Phone: 4044981307

Criteria for Selecting Proposals

Applications are reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the Office of Surveillance, Epidemiology and Laboratory Services (OSELS) and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements.

CDC conducts a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information within the individual funding announcement. Applicants will be notified if their application did not meet program requirements.

Co-founders William Mann and David Mravyan devised the Sensimat during a mandatory project for their MBA at the Richard Ivey School of Business in Canada. Sensimat is a device that helps manage and assess pressure among wheelchair users.

More Federal Domestic Assistance Programs

Federal Oil and Gas Royalty Management | Very Low to Moderate Income Housing Loans - Guaranteed | Appalachian Development Highway System | Magnet Schools Assistance | PPHF-2012: Health Care Surveillance/Health Statistics Surveillance Program Announcement: Behavioral  |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy

Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders